Q&A: Researcher investigates pharmacological approaches to breast cancer prevention
In a new thesis, Mattias Hammarström studied whether lower doses of tamoxifen and also its active metabolite endoxifen for direct administration, as a preventive medication could reduce side effects while still affecting breast tissue in healthy women. The findings suggest that lower doses of tamoxifen and a low dose of endoxifen may offer a better balance between biological effects and side…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
